Clinical trial
Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host…
NCT00043147 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00043147 |
|---|---|
| Title | Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease |
| Official title | A Phase III, Randomized, Placebo-Controlled, Multicenter Study of the Safety, Efficacy, and Pharmacokinetics of Oral Beclomethasone 17, 21-Dipropionate (BDP) in Conjunction With Ten Days of High-Dose Prednisone Therapy in the Treatment of Patients With Grade II Graft vs. Host Disease With… |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Graft Versus Host Disease |
| Intervention type | Drug |
| Interventions | beclomethasone dipropionate, methylprednisolone, prednisone |
| Start date | Apr 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | May 30, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: